leadf
logo-loader
TSX-V:LXG OTCQB:LXXGF

LexaGene Holdings Inc.

Receive alerts
Market:
TSX-V
Market Cap:
$93.24 m
Price
0.82 CAD
Change
0.00%
52 weeks high
1.28
52 weeks low
0.43

In brief

LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more.

Snapshot

The firm will soon start manufacturing its flagship LX Genetic Analyzer for rapid pathogen detection, with an anticipated commercial launch in 2020